Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Azitra expands technical team in Farmington

Azitra has announced the appointment of two distinguished scientists to expand the technical team and lead the expansion of its development programs. Travis Whitfill, co-founder, will...

| By Kelley Gipson

Bioarray to present at Cancer Cluster Showcase

Bioarray Genetics has been selected to present at the 2019 International Cancer Cluster Showcase as part of its North American and European cutting-edge oncology innovations group....

| By Kelley Gipson

Achillion reports positive interim data re ACH-4471

Achillion Pharmaceuticals has reported positive interim data from a Phase 2 paroxysmal nocturnal hemoglobinuria (PNH) trial assessing the safety and effectiveness of its oral small...

| By Kelley Gipson

NextCure reports IPO pricing

NextCure announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00 per share....

| By Kelley Gipson

Trevi Therapeutics raises $55M in IPO

Trevi Therapeutics has gone public, selling 5.5 million shares at $10 a share and raising $55 million. The company, which is developing a drug for...

| By Kelley Gipson

SpringWorks initiates Phase 1b trial of MEK inhibitor

SpringWorks Therapeutics reports that the first patient has been dosed in a Phase 1b study to evaluate the combination of SpringWorks Therapeutics’ investigational MEK inhibitor,...

| By Kelley Gipson

Yale-New Haven plans neuroscience center

Yale-New Haven Hospital has unveiled plans to build up its St. Raphael campus with a 505,000-square foot, $838 million neuroscience center for research and treatment...

| By Bill Kelly

BioCT welcomes new member KPMG

KPMG LLP provides tax, audit and advisory services (including strategy, risk, regulatory and M&A) to over 500 life sciences clients in the northeast region. The...